[Congressional Bills 115th Congress] [From the U.S. Government Publishing Office] [H.R. 5926 Introduced in House (IH)] <DOC> 115th CONGRESS 2d Session H. R. 5926 To require the Secretary of Health and Human Services to issue guidelines for prescribing naloxone, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES May 23, 2018 Mr. Keating (for himself and Mr. Rothfus) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To require the Secretary of Health and Human Services to issue guidelines for prescribing naloxone, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Naloxone Guidelines Act of 2018''. SEC. 2. GUIDELINES FOR PRESCRIBING NALOXONE. (a) In General.--Not later than 180 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall issue guidelines for prescribing an opioid overdose reversal drug. (b) Contents.--In issuing guidelines under subsection (a), the Secretary shall address the following: (1) Co-prescribing an opioid overdose reversal drug in conjunction with any prescribed opioid. (2) Dosage safety. (3) Prescribing an opioid overdose reversal drug to an individual other than a patient. (4) Standing orders. (5) Other distribution, education, and safety measures as determined necessary. <all>